We’ve moved to
AXC
AxellaCoin
Powering innovation in clinical research through blockchain.
AxellaCoin (AXC) is a Cardano-native utility token developed by Axella Research to fund early-stage biotech innovation — including compassionate use and expanded access clinical trials.AXC allows researchers, clinicians, and communities to support meaningful real-world impact through decentralized funding.
Email: [email protected]
⚖️ AXC Legal DisclaimerAxellaCoin (AXC) is a utility token created to support decentralized clinical research, including compassionate use programs and early-stage trials.AXC is not a security. It does not represent equity, ownership, dividends, or profit rights in any entity. It has not been registered under securities laws, and should not be acquired with an expectation of financial return.Utility Purposes Only:
- Support for trial funding initiatives
- Participation in Stake-to-Support campaigns
- Access to CRO services (future phase)
- Governance participation via DAO (future)When AXC is used to fund biotech startups, any resulting equity, warrants, or royalties are held by Axella Research or an affiliated treasury. These assets are not distributed to token holders, but may be used to reinvest in future research.This structure enables a sustainable funding ecosystem—not a profit-sharing scheme.The value of AXC may fluctuate. By using AXC, you acknowledge that it is a utility token, not a financial instrument, and is used at your own discretion.🏛️Disclosure on Token Valuation and Tax Treatment:AxellaCoin (AXC) is internally valued at $0.50 per token for the purposes of grant milestones, founder vesting schedules, and long-term project alignment. This valuation reflects AxellaCoin’s target price based on its utility, funding capacity, and projected growth.However, for tax, accounting, and regulatory purposes, all AXC transactions are recognized at their Fair Market Value (FMV) at the time of transaction. FMV is based on real-time market pricing as determined by publicly available decentralized exchanges (e.g., Minswap.io).Any grants issued, service payments made, or income received in AXC will be reported at FMV, regardless of the internal peg. This approach ensures compliance with IRS guidelines and supports transparent financial reporting across all stakeholders.Future white paper revisions, grant letters, and roadmap documents will consistently reflect this dual structure, citing both internal token valuation and FMV where applicable.
